Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group. de réir Gogas, H, Polyzos, A, Stavrinidis, I, Frangia, K, Tsoutsos, D, Panagiotou, P, Markopoulos, C, Papadopoulos, O, Pectasides, D, Mantzourani, M, Middleton, M, Vaiopoulos, G, Fountzilas, G